Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma

Organ preservation protocols are commonly used as first line therapy for advanced laryngeal cancer. Recurrence thereafter is associated with poor survival. The aim of this study is to identify genetic alterations associated with survival among patients with recurrent laryngeal cancer undergoing salv...

Full description

Bibliographic Details
Main Authors: Molly E. Heft Neal, Apurva D. Bhangale, Andrew C. Birkeland, Jonathan B. McHugh, Andrew G. Shuman, Andrew J. Rosko, Paul L. Swiecicki, Matthew E. Spector, J. Chad Brenner
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/11/3081
_version_ 1797550193088921600
author Molly E. Heft Neal
Apurva D. Bhangale
Andrew C. Birkeland
Jonathan B. McHugh
Andrew G. Shuman
Andrew J. Rosko
Paul L. Swiecicki
Matthew E. Spector
J. Chad Brenner
author_facet Molly E. Heft Neal
Apurva D. Bhangale
Andrew C. Birkeland
Jonathan B. McHugh
Andrew G. Shuman
Andrew J. Rosko
Paul L. Swiecicki
Matthew E. Spector
J. Chad Brenner
author_sort Molly E. Heft Neal
collection DOAJ
description Organ preservation protocols are commonly used as first line therapy for advanced laryngeal cancer. Recurrence thereafter is associated with poor survival. The aim of this study is to identify genetic alterations associated with survival among patients with recurrent laryngeal cancer undergoing salvage laryngectomy. Sixty-two patients were sequenced using a targeted panel, of which twenty-two also underwent transcriptome sequencing. Alterations were grouped based on biologic pathways and survival outcomes were assessed using Kaplan-Meier analysis and multivariate cox regression. Select pathways were evaluated against The Cancer Genome Atlas (TCGA) data. Patients with mutations in the Oxidation pathway had significantly worse five-year disease specific survival (1% vs. 76%, <i>p</i> = 0.02), while mutations in the HN-Immunity pathway were associated with improved five-year disease specific survival (100% vs. 62%, <i>p</i> = 0.02). Multivariate analysis showed mutations in the Oxidation pathway remained an independent predictor of disease specific survival (HR 3.2, 95% CI 1.1–9.2, <i>p</i> = 0.03). Transcriptome analysis of recurrent tumors demonstrated that alterations in the Oxidation pathway were associated a positive Ragnum hypoxia signature score, consistent with enhanced pathway activity. Further, TCGA analyses demonstrated the prognostic value of oxidation pathway alterations in previously untreated disease. Alterations in the Oxidation pathway are associated with survival among patients with recurrent laryngeal cancer. These prognostic genetic biomarkers may inform precision medicine protocols and identify putatively targetable pathways to improve survival in this cohort.
first_indexed 2024-03-10T15:25:02Z
format Article
id doaj.art-db0596eb9b844299b3e61ac6fcec10cb
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T15:25:02Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-db0596eb9b844299b3e61ac6fcec10cb2023-11-20T18:07:59ZengMDPI AGCancers2072-66942020-10-011211308110.3390/cancers12113081Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell CarcinomaMolly E. Heft Neal0Apurva D. Bhangale1Andrew C. Birkeland2Jonathan B. McHugh3Andrew G. Shuman4Andrew J. Rosko5Paul L. Swiecicki6Matthew E. Spector7J. Chad Brenner8Department of Otolaryngology–Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48109, USADepartment of Otolaryngology–Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48109, USADepartment of Otolaryngology–Head and Neck Surgery, University of California Davis, Sacramento, CA 95817, USADepartment of Pathology, University of Michigan, Ann Arbor, MI 48109, USADepartment of Otolaryngology–Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48109, USADepartment of Otolaryngology–Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48109, USARogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Otolaryngology–Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48109, USADepartment of Otolaryngology–Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48109, USAOrgan preservation protocols are commonly used as first line therapy for advanced laryngeal cancer. Recurrence thereafter is associated with poor survival. The aim of this study is to identify genetic alterations associated with survival among patients with recurrent laryngeal cancer undergoing salvage laryngectomy. Sixty-two patients were sequenced using a targeted panel, of which twenty-two also underwent transcriptome sequencing. Alterations were grouped based on biologic pathways and survival outcomes were assessed using Kaplan-Meier analysis and multivariate cox regression. Select pathways were evaluated against The Cancer Genome Atlas (TCGA) data. Patients with mutations in the Oxidation pathway had significantly worse five-year disease specific survival (1% vs. 76%, <i>p</i> = 0.02), while mutations in the HN-Immunity pathway were associated with improved five-year disease specific survival (100% vs. 62%, <i>p</i> = 0.02). Multivariate analysis showed mutations in the Oxidation pathway remained an independent predictor of disease specific survival (HR 3.2, 95% CI 1.1–9.2, <i>p</i> = 0.03). Transcriptome analysis of recurrent tumors demonstrated that alterations in the Oxidation pathway were associated a positive Ragnum hypoxia signature score, consistent with enhanced pathway activity. Further, TCGA analyses demonstrated the prognostic value of oxidation pathway alterations in previously untreated disease. Alterations in the Oxidation pathway are associated with survival among patients with recurrent laryngeal cancer. These prognostic genetic biomarkers may inform precision medicine protocols and identify putatively targetable pathways to improve survival in this cohort.https://www.mdpi.com/2072-6694/12/11/3081HNSCClarynxNrf2/Keap1oxidation
spellingShingle Molly E. Heft Neal
Apurva D. Bhangale
Andrew C. Birkeland
Jonathan B. McHugh
Andrew G. Shuman
Andrew J. Rosko
Paul L. Swiecicki
Matthew E. Spector
J. Chad Brenner
Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma
Cancers
HNSCC
larynx
Nrf2/Keap1
oxidation
title Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma
title_full Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma
title_fullStr Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma
title_full_unstemmed Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma
title_short Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma
title_sort prognostic significance of oxidation pathway mutations in recurrent laryngeal squamous cell carcinoma
topic HNSCC
larynx
Nrf2/Keap1
oxidation
url https://www.mdpi.com/2072-6694/12/11/3081
work_keys_str_mv AT mollyeheftneal prognosticsignificanceofoxidationpathwaymutationsinrecurrentlaryngealsquamouscellcarcinoma
AT apurvadbhangale prognosticsignificanceofoxidationpathwaymutationsinrecurrentlaryngealsquamouscellcarcinoma
AT andrewcbirkeland prognosticsignificanceofoxidationpathwaymutationsinrecurrentlaryngealsquamouscellcarcinoma
AT jonathanbmchugh prognosticsignificanceofoxidationpathwaymutationsinrecurrentlaryngealsquamouscellcarcinoma
AT andrewgshuman prognosticsignificanceofoxidationpathwaymutationsinrecurrentlaryngealsquamouscellcarcinoma
AT andrewjrosko prognosticsignificanceofoxidationpathwaymutationsinrecurrentlaryngealsquamouscellcarcinoma
AT paullswiecicki prognosticsignificanceofoxidationpathwaymutationsinrecurrentlaryngealsquamouscellcarcinoma
AT matthewespector prognosticsignificanceofoxidationpathwaymutationsinrecurrentlaryngealsquamouscellcarcinoma
AT jchadbrenner prognosticsignificanceofoxidationpathwaymutationsinrecurrentlaryngealsquamouscellcarcinoma